Previously undisclosed agreements regarding the sale of COVID-19 vaccines between Pfizer and the Israeli Ministry of Health were revealed to the public for the first time on Feb. 20.
The documents include the Confidential Disclosure Agreement that was signed on July 12, 2020; the Binding Term Sheet signed on Nov. 13, 2020; the Manufacturing and Supply (M&S) agreement signed on Dec. 1, 2020; three amendments to the M&S agreement dated February and April 2021, and a Supplementary agreement signed on March 11, 2021.